不同抗凝策略对心房颤动导管消融心脏压塞并发症处理的影响The management of cardiac tamponade complications during catheter ablation of atrial fibrillation using different periprocedure anticoagulation strategies
桑才华,董建增,龙德勇,喻荣辉,汤日波,白融,刘念,陈珂,蒋晨曦,宁曼,李松南,陈英伟,马长生
摘要(Abstract):
目的观察围术期不同抗凝策略对心房颤动(房颤)导管消融心脏压塞并发症处理的影响。方法连续入选2007年1月至2013年12月4487例导管消融术中发生心脏压塞并发症的患者27例,发生率0.6%。按围术期抗凝策略分组:第1组患者术前停用华法林3~5 d,以低分子肝素皮下注射桥接过渡;第2组患者围术期不中断华法林抗凝,国际标准化比值(INR)控制在1.8~2.5。对比两组患者心脏压塞并发症的临床处理及转归。结果共27例急性心脏压塞的患者入选,其中第1组18例,第2组9例。除术前INR(0.9±0.1比2.3±0.5,P<0.001)之外,两组基线资料包括年龄、左心房前后径、血小板计数、术中肝素用量、术中活化凝血时间(ACT)等均差异无统计学意义。所有患者均在剑突下穿刺心包成功并置入6 F猪尾管引流,两组心包积液引流量分别为(365±222)ml和(506±300)ml,P=0.137;分别有10例(55.6%)和7例(77.8%)应用了自体血回输技术,P=0.406;分别有2例(11.1%)和1例(11.1%)心包引流无效进行急诊外科开胸,P>0.999;两组患者住院时间分别为(9.6±3.3)d和(12.1±4.5)d,P=0.167。未发生其他严重并发症。结论房颤导管消融围术期不中断华法林抗凝对急性心脏压塞并发症的处理及预后无明显不良影响。
关键词(KeyWords): 心房颤动;导管消融;心脏压塞;抗凝
基金项目(Foundation):
作者(Author): 桑才华,董建增,龙德勇,喻荣辉,汤日波,白融,刘念,陈珂,蒋晨曦,宁曼,李松南,陈英伟,马长生
参考文献(References):
- [1]Cappato R,Calkins H,Chen SA,et al.Updated worldwide surveyon the methods,efficacy,and safety of catheter ablation for human atrial fibrillation.Circ Arrhythm Electrophysiol,2010,3:32-38.
- [2]Wazni OM,Beheiry S,Fahmy T,et al.Atrial fibrillation ablation in patients with therapeutic international normalized ratio:Comparison of strategies of anticoagulation management in the periprocedural period.Circulation,2007,116:2531-2534.
- [3]Hussein AA,Martin DO,Saliba W,et al.Radiofrequency ablation of atrial fi brillation under therapeutic international normalized ratio:A safe and efficacious periprocedural anticoagulation strategy.Heart rhythm,2009,6:1425-1429.
- [4]Di Biase L,Burkhardt JD,Mohanty P,et al.Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation:The impact of periprocedural therapeutic international normalized ratio.Circulation,2010,121:2550-2556.
- [5]Latchamsetty R,Gautam S,Bhakta D,et al.Management and outcomes of cardiac tamponade during atrial fiabrillation ablation in the presence of therapeutic anticoagulation with warfarin.Heart Rhythm,2011,8:805-808.
- [6]马长生,董建增,刘旭,等.右前斜45°透视指引下房间隔穿刺术方法学评价.中国介入心脏病学杂志,2003,11:190-193.
- [7]Sang C,Jiang C,Dong J,et al.A new method to evaluate linear block at the left atrial roof:Is it reliable without pacing?J Cardiovasc Electrophysiol,2010,21:741-746.
- [8]董建增,马长生,刘兴鹏,等.单导管隔离肺静脉前庭的方法学评价.中国介入心脏病学杂志,2009,16:141-144.
- [9]Gao LY,Tang RB,Dong JZ,et al.Autotransfusion in the management of cardiac tamponade occurring during catheter ablation of atrial fi brillation.Chinese medical journal,2010,123:961-963.
- [10]汤日波,董建增,刘兴鹏等.导管消融心房颤动致心脏压塞经急诊开胸修补与心外膜消融治疗一例.中华心血管病杂志,2008,36:434.
- [11]Oral H,Chugh A,Ozaydin M,et al.Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation.Circulation,2006,114:759-765.